	Ebit		Date
AbbVie	USD 5.81B	4.36B	2025-12
Agios Pharmaceuticals	USD -121.58M	4.71M	2025-12
Alnylam Pharmaceuticals	USD 29.4M	59.36M	2025-12
Amgen	USD 3.96B	464M	2025-12
Arrowhead Research	USD 40.81M	17.01M	2025-12
Astellas Pharma	JPY 134.54B	30.13B	2025-12
AstraZeneca	USD 2.97B	4.48B	2025-12
Bayer	EUR -399M	363M	2025-09
Biogen	USD 659.6M	157M	2025-09
BioMarin Pharmaceutical	USD 198.39M	230.08M	2025-12
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Daiichi Sankyo	JPY 89.54B	42.01B	2025-12
Eli Lilly	USD 8.99B	1.57B	2025-12
Exelixis	USD 235.91M	20.45M	2025-12
Gilead Sciences	USD 2.96B	551M	2025-12
GlaxoSmithKline	GBP 1.44B	1.35B	2025-12
Incyte	USD 383.88M	47.44M	2025-12
Ionis Pharmaceuticals	USD -215M	54.82M	2025-12
Merck	USD 6.24B	1.32B	2025-12
Moderna	USD -857M	597M	2025-12
Nektar Therapeutics	USD -34.34M	3.68M	2024-09
Novartis	USD -9.19B	13.87B	2025-06
Novartis	USD 4.48B	343M	2025-09
Pfizer	USD 4.65B	71M	2025-12
Puma Biotechnology	USD -2.2M	11.41M	2024-06
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12

Agios Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.